Gary H. Lyman, MD, MPH

Articles by Gary H. Lyman, MD, MPH

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach

ByScott D. Ramsey, MD, PhD,Gary H. Lyman, MD, MPH

April 16th 2015

Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy

BySuja S. Rajan, MHA, MS, PhD,William R. Carpenter, MHA, PhD,Sally C. Stearns, PhD,Gary H. Lyman, MD, MPH

February 13th 2013

Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.

Latest Updated Articles

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach
April 16th 2015
Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy
February 13th 2013

Gary H. Lyman, MD, MPH

Articles by Gary H. Lyman, MD, MPH

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach

Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy

Latest Updated Articles

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

US Employer Health Care Costs Projected to Rise 9.5% in 2027

Student Mental Health, Success Tied to Future Health and Affordability

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Mobile Integrated Health Valuable in Heart Failure, but Payment Lags